Literature DB >> 35582017

A Cross-Disciplinary View of Testing and Bioinformatic Analysis of SARS-CoV-2 and Other Human Respiratory Viruses in Pandemic Settings.

Md Arafat Hossain1, Barbara Brito-Rodriguez2, Lisa M Sedger3, John Canning4.   

Abstract

The SARS-Coronavirus-2 (SARS-CoV-2) infectious disease, COVID-19, has spread rapidly, resulting in a global pandemic with significant mortality. The combination of early diagnosis via rapid screening, contact tracing, social distancing and quarantine has helped to control the pandemic. The absence of real time response and diagnosis is a crucial technology shortfall and is a key reason why current contact tracing methods are inadequate to control spread. In contrast, current information technology combined with a new generation of near-real time tests offers consumer-engaged smartphone-based "lab-in-a-phone" internet-of-things (IoT) connected devices that provide increased pandemic monitoring. This review brings together key aspects required to create an entire global diagnostic ecosystem. Cross-disciplinary understanding and integration of both mechanisms and technologies for effective detection, incidence mapping and disease containment in near real-time is summarized. Available measures to monitor and/or sterilize surfaces, next-generation laboratory and smartphone-based diagnostic approaches can be brought together and networked for instant global monitoring that informs Public Health policy. Cloud-based analysis enabling real-time mapping will enable future pandemic control, drive the suppression and elimination of disease spread, saving millions of lives globally. A new paradigm is introduced - scaled and multiple diagnostics for mapping and spreading of a pandemic rather than traditional accumulation of individual measurements. This can do away with the need for ultra-precise and ultra-accurate analysis by taking mass measurements that can relax tolerances and build resilience through networked analytics and informatics, the basis for novel swarm diagnostics. These include addressing ethical standards, local, national and international collaborative engagement, multidisciplinary and analytical measurements and standards, and data handling and storage protocols.

Entities:  

Keywords:  Antibody test; COVID-19; Internet-of-Things; LAMP test; PCR; SARS-CoV; antigen test; bioinformatics; lab-in-a-phone; point-of-care test

Year:  2021        PMID: 35582017      PMCID: PMC8843158          DOI: 10.1109/ACCESS.2021.3133417

Source DB:  PubMed          Journal:  IEEE Access        ISSN: 2169-3536            Impact factor:   3.476


  113 in total

1.  Genosensors for differential detection of Zika virus.

Authors:  Daniel Alzate; Sebastian Cajigas; Sara Robledo; Carlos Muskus; Jahir Orozco
Journal:  Talanta       Date:  2019-12-16       Impact factor: 6.057

2.  Rapid, label-free CD4 testing using a smartphone compatible device.

Authors:  Manoj Kumar Kanakasabapathy; Hardik J Pandya; Mohamed Shehata Draz; Manjyot Kaur Chug; Magesh Sadasivam; Shreya Kumar; Behzad Etemad; Vinish Yogesh; Mohammadali Safavieh; Waseem Asghar; Jonathan Z Li; Athe M Tsibris; Daniel R Kuritzkes; Hadi Shafiee
Journal:  Lab Chip       Date:  2017-08-22       Impact factor: 6.799

3.  Nanofabrication of a Solid-State, Mesoporous Nanoparticle Composite for Efficient Photocatalytic Hydrogen Generation.

Authors:  Yusuke Yamada; Hideyuki Tadokoro; Masood Naqshbandi; John Canning; Maxwell J Crossley; Tomoyoshi Suenobu; Shunichi Fukuzumi
Journal:  Chempluschem       Date:  2016-05-20       Impact factor: 2.863

Review 4.  Commercial Smartphone-Based Devices and Smart Applications for Personalized Healthcare Monitoring and Management.

Authors:  Sandeep Kumar Vashist; E Marion Schneider; John H T Luong
Journal:  Diagnostics (Basel)       Date:  2014-08-18

5.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

6.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Authors:  Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan
Journal:  Science       Date:  2020-02-19       Impact factor: 47.728

7.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

8.  Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey.

Authors:  Klang Shmuel; Megiddo Dalia; Lapidot Tair; Naparstek Yaakov
Journal:  Expert Rev Anti Infect Ther       Date:  2021-04-01       Impact factor: 5.091

9.  Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.

Authors:  Xiaolong Tian; Cheng Li; Ailing Huang; Shuai Xia; Sicong Lu; Zhengli Shi; Lu Lu; Shibo Jiang; Zhenlin Yang; Yanling Wu; Tianlei Ying
Journal:  Emerg Microbes Infect       Date:  2020-02-17       Impact factor: 7.163

10.  Evidence for Gastrointestinal Infection of SARS-CoV-2.

Authors:  Fei Xiao; Meiwen Tang; Xiaobin Zheng; Ye Liu; Xiaofeng Li; Hong Shan
Journal:  Gastroenterology       Date:  2020-03-03       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.